Form D · Biotechnology
BIOASSETS DEVELOPMENT CORP
Wellesley, MA · CIK 0001365870
Offering snapshot reported Sep 3, 2009 · SEC filing
- Reported sold
- $3.91M Offering amount: $3.91M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2009 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,761,759 → $3,911,759
- Reported investors29 → 31
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 3, 2009 | Amendment | $3,911,759 | $150,000vs Jul 29, 2009 | 31 | SEC filing |
| Jul 29, 2009 | Initial | $3,761,759 | No comparison | 29 | SEC filing |
| May 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-90742
Source: Form D, filed Sep 3, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James R. Gorman | Director, Executive |
| Robert Kamen | Director, Executive |
| Hansen A. Yuan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
888 Worcester Street Suite 95
Wellesley, MA, 02482
Wellesley, MA, 02482